NasdaqGM - Nasdaq Real Time Price USD
LifeMD, Inc. (LFMD)
8.22
+0.06
+(0.73%)
As of 1:59:09 PM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
212,453.84
212,453.84
152,547.01
119,033.52
92,875.81
Cost of Revenue
24,068.48
24,068.48
18,900.46
18,668.03
17,995.39
Gross Profit
188,385.36
188,385.36
133,646.54
100,365.49
74,880.41
Operating Expense
204,530.04
204,530.04
148,135.82
140,051.68
129,181.49
Operating Income
-16,144.68
-16,144.68
-14,489.27
-39,686.19
-54,301.08
Net Non Operating Interest Income Expense
-2,181.82
-2,181.82
-2,596.59
-1,275.95
-3,019.72
Other Income Expense
--
--
-325.20
-3,698.20
-3,995.56
Pretax Income
-18,326.50
-18,326.50
-17,411.06
-44,660.33
-61,316.36
Tax Provision
402
402
428
360.70
7.70
Net Income Common Stockholders
-21,987.98
-21,987.98
-23,702.24
-48,641.91
-61,769.18
Diluted NI Available to Com Stockholders
-21,987.98
-21,987.98
-23,702.24
-48,641.91
-61,769.18
Basic EPS
-0.64
-0.53
-0.70
-1.57
-2.29
Diluted EPS
-0.64
-0.53
-0.70
-1.57
-2.29
Basic Average Shares
39,828.41
41,196.29
33,905.16
30,976.46
27,007.96
Diluted Average Shares
39,828.41
41,196.29
33,905.16
30,976.46
27,007.96
Total Operating Income as Reported
-16,144.68
-16,144.68
-14,489.27
-43,447.78
-54,301.08
Total Expenses
228,598.52
228,598.52
167,036.28
158,719.71
147,176.89
Net Income from Continuing & Discontinued Operation
-18,881.73
-18,881.73
-20,595.99
-45,535.66
-60,897.70
Normalized Income
-18,881.73
-18,881.73
-20,339.09
-42,614.08
-57,980.95
Net Interest Income
-2,181.82
-2,181.82
-2,596.59
-1,275.95
-3,019.72
EBIT
-16,144.68
-16,144.68
-14,489.27
-39,686.19
-54,301.08
EBITDA
-6,653.16
-6,653.16
-7,889.05
-35,915.95
-53,432.32
Reconciled Cost of Revenue
24,068.48
24,068.48
18,900.46
18,668.03
17,995.39
Reconciled Depreciation
9,491.52
9,491.52
6,600.23
3,770.23
868.76
Net Income from Continuing Operation Net Minority Interest
-18,881.73
-18,881.73
-20,595.99
-45,535.66
-60,897.70
Total Unusual Items Excluding Goodwill
0
0
-325.20
-3,698.20
-3,995.56
Total Unusual Items
0
0
-325.20
-3,698.20
-3,995.56
Normalized EBITDA
-6,653.16
-6,653.16
-7,563.85
-32,217.76
-49,436.77
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
-68.29
-776.62
-1,078.80
12/31/2021 - 1/29/2008
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TALK Talkspace, Inc.
3.0150
-0.82%
FOXO FOXO Technologies Inc.
0.6854
-4.73%
ICCT iCoreConnect Inc.
1.8015
-8.09%
CCLD CareCloud, Inc.
1.9500
+5.98%
CERT Certara, Inc.
12.14
+2.23%
WORX SCWorx Corp.
0.7076
+29.12%
TDOC Teladoc Health, Inc.
7.11
+0.35%
TEM Tempus AI, Inc.
62.22
-4.60%
DOCS Doximity, Inc.
59.53
+0.30%
BTSG BrightSpring Health Services, Inc.
22.67
+0.67%